HPGC: Norfloxacin capsules (0.1g) passed the consistency evaluation of quality and efficacy for generic drugs
I'm PortAI, I can summarize articles.
HPGC announced that its norfloxacin capsules (0.1g) have passed the consistency evaluation of quality and efficacy for generic drugs by the National Medical Products Administration. This approval will provide greater support for the drug in areas such as medical insurance reimbursement and procurement by medical institutions, helping to expand market share and enhance competitiveness, while also accumulating experience for the company's future generic drug products
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments